A novel monoclonal antibody with immunestimulatory and anti-tumor properties

Keyphrases

• Lymphocytes 100%
• Tumor 100%
• Tumor Regression 100%
• Antitumor Effect 100%
• SCID Mice 100%
• Antitumor Properties 100%
• Novel Antibodies 100%
• Synergistic Effect 50%
• Clinical Application 50%
• Melanoma 50%
• Human Tumors 50%
• FACS Analysis 50%
• Synergize 50%
• Tumor Cells 50%
• In Vitro Study 50%
• Human Melanoma 50%
• Engraftment 50%
• Host Immune Response 50%
• Human Lymphocytes 50%
• Mouse Tumor Model 50%
• Tumor-bearing Mice 50%
• Lymphocyte Proliferation 50%
• Carcinoma 50%
• Splenocytes 50%
• In Vivo Data 50%
• B16 Melanoma 50%
• Adoptive Transfer 50%
• Prolonged Survival 50%
• CD56 50%
• Daudi 50%
• Pulmonary Lesions 50%
• B-lymphoblastoid Cell Lines 50%
• Human PBL 50%

Immunology and Microbiology

• Monoclonal Antibody 100%
• Mouse 100%
• Lymphocyte 60%
• SCID Mouse 40%
• CD3 Antigen 20%
• Immune System 20%
• Fluorescence Activated Cell Sorting 20%
• Tumor Cell 20%
• Engraftment 20%
• Peripheral Blood Lymphocyte 20%
• Lymphocyte Proliferation 20%
• Splenocyte 20%
• B-Lymphoblastoid Cell Line 20%